4亿元，梅花创投再出手上市公司

Group 1 - ST Zhongzhu announced that Meihua Investment plans to acquire 10.38% of its shares for 403 million yuan, with the transaction involving major shareholders Guangzhou Yunying Capital and Zheng Zixian [1][2] - After the transaction, Meihua Investment will become the second largest shareholder of ST Zhongzhu, while the current shareholders will no longer hold any shares [2] - ST Zhongzhu's main business includes pharmaceutical manufacturing, medical services, medical devices, and real estate, with a revenue of 433 million yuan in the first three quarters of 2025, representing a year-on-year growth of 12.82% [2] Group 2 - Meihua Investment, established in July 2025, is led by Wu Shichun, who also founded Meihua Venture Capital in 2014 [3] - In 2023, Meihua Investment has actively participated in the secondary market, acquiring significant stakes in listed companies, including becoming the second largest shareholder of Mengjie Shares and the largest shareholder of ST Lutong [3] - The introduction of policies supporting private equity funds in acquiring listed companies has led to an increase in such cases, although the long-term intentions of venture capital firms remain to be observed [3][4] Group 3 - The long-term goal of mergers and acquisitions based on industrial integration allows venture capital firms to accumulate industry resources and optimize their research and investment systems, creating a positive cycle between primary and secondary markets [4]